Important: this page has been automatically translated using AI technology. Please consult your doctor before acting on any health information or email enquiries@arthritis-uk.org for further support.
Upadacitinib (Rinvoq) is a JAK inhibitor drug used to treat joint damage in rheumatoid arthritis and psoriatic arthritis.
Ustekinumab is used to treat psoriasis and psoriatic arthritis. Find out how long it takes to work, how it’s taken and possible side-effects.